Latest S-1 registration statements

Catalyst Crew Technologies Corp. is offering 40,000,000 shares of common stock at $0.01 per share to raise capital for its facial recognition technology development.

QT Imaging Holdings has filed a registration statement for the resale of up to 8.8 million shares of its common stock by selling securityholders, following a recent private placement.

Nxu Inc. has filed an amendment to its S-1 registration statement, covering the resale of up to 114.5 million shares of Class A common stock by selling stockholders, as the company navigates a strategic merger with Verde Bioresins.

Thoughtful Media Group has filed an amendment to its S-1 registration statement, detailing its upcoming initial public offering and a concurrent resale offering.

Digital Ally, Inc. has filed an amendment to its registration statement to allow selling stockholders to resell up to 808,377 shares of common stock.

Processa Pharmaceuticals has filed an amendment to its registration statement for a public offering of up to 9,400,705 shares of common stock, pre-funded warrants, and common warrants.

Inflection Point Acquisition Corp. III, a special purpose acquisition company, has filed an amendment to its S-1 registration statement for a proposed $220 million initial public offering.

OneMeta Inc. amends its share acquisition agreement with Metalanguage Corp. and Saul Leal, while also preparing for a public offering and Nasdaq listing.

Soluna Holdings files an amendment to its registration statement for a common stock offering, detailing warrants, agreements with YA II PN, Ltd., and Chuntao Zhou.

Virpax Pharmaceuticals is offering up to 16,849,200 shares of common stock and pre-funded warrants to raise capital for clinical trials, working capital, and general corporate purposes.

Mustang Bio plans a public offering of common stock and warrants to fund its CAR T therapy development for hematologic malignancies and solid tumors.

Stardust Power aims to bolster its financial position by offering shares of common stock and warrants, targeting proceeds of $12.5 million.

Armlogi Holding Corp. has filed an amendment to its Form S-1 registration statement for the resale of up to 13,168,147 shares of common stock by YA II PN, LTD.

NusaTrip Inc. has filed an amendment to its Form S-1 registration statement for its initial public offering, planning to list on the Nasdaq Capital Market under the symbol NUTR.

Shuttle Pharmaceuticals is registering for resale 1,464,268 shares of common stock underlying convertible notes and 329,461 shares of common stock issuable upon exercise of warrants, all issued in a recent private placement.

ReShape Lifesciences has filed an amendment to its S-1 registration statement, detailing the potential resale of up to 2,112,072 shares of common stock by a selling stockholder.

Hennessy Capital Investment Corp. VII, a newly formed blank check company, has filed an amendment to its registration statement for a $175 million initial public offering, focusing on acquisitions in the industrial technology and energy transition sectors.

Aclarion, Inc. has filed a registration statement to offer up to $8.1 million in additional securities, including common stock and warrants.

Nano Nuclear Energy is registering for resale up to 2,500,002 shares of its common stock and an equal number of shares issuable upon exercise of warrants, totaling approximately $128.8 million.

Thunder Power Holdings seeks to register the resale of up to $100 million in common stock by Westwood Capital Group and 8,570 shares by Benjamin Securities.

Enveric Biosciences is offering shares of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants, to raise capital for product development and general corporate purposes.

Silexion Therapeutics launches a best-efforts offering to raise up to $5 million for advancing its RNAi-based cancer therapies, including SIL-204B for pancreatic cancer.

Northann Corp. has filed an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 30,084,400 shares of common stock acquired through various acquisitions and private placements.

Go Green Global Technologies Corp. has entered into a promissory note agreement with AJB Capital Investments LLC for a $90,000 loan, which includes conversion rights under certain conditions.

Hepion Pharmaceuticals plans to offer shares of common stock, pre-funded warrants, and common stock purchase warrants in a reasonable best efforts offering.

Adagio Medical Holdings seeks to register the resale of up to 67.9 million common shares by existing stockholders, including shares from PIPE investors, convertible noteholders, and the Sponsor.

Scienture Holdings is registering the resale of up to 4.3 million shares of common stock by selling stockholders, including shares related to ELOC and Securities Purchase Agreements.

Hyperscale Data, Inc. files an amendment to its registration statement for the potential resale of up to 1,500,000 shares of its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock by Orion Equity Partners LLC.

Adagio Medical Holdings seeks to register the resale of shares by selling stockholders following its recent business combination, involving convertible notes and warrants.

Palvella Therapeutics files an amendment to its registration statement for the potential resale of up to 5,634,504 shares of its common stock by selling stockholders.